Clinical Trials in Phoenix

Showing 7441-7460 of 16,646 trials

ALS Testing Through Home-based Outcome Measures

NCT03016897

ALS AT HOME is a single-center study of up to 150 participants being done to determine the extent to which frequent sampling can improve the qualities of outcome measures collected at home by study participants.

Amyotrophic Lateral Sclerosis

Jeremy Shefner144 participantsStarted Feb 2017

Phoenix, Arizona, United States

COMPLETEDPhase 2< 1 mile

Sargramostim Use in COVID-19 to Recover Patient Health

NCT04707664

The purpose of this research is to understand if the study drug, also called sargramostim or Leukine®, can help prevent the worsening of COVID-19 when the study drug is inhaled. This study will also help researchers understand if inhaled sargramostim can help prevent visits to the emergency room or hospitalization, or death.

Covid19SARS-CoV Infection

Partner Therapeutics, Inc.600 participantsStarted Apr 2021

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Canoga Park, California, United States +34 more locations

ALS Testing Through Home-based Outcome Measures

Sargramostim Use in COVID-19 to Recover Patient Health

Find Trials by Condition in Phoenix

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Validation of a Salivary miRNA Diagnostic Test for ASD

Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

A Study of Modified Stem Cells in Stable Ischemic Stroke